Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [
Digital PET
List mode acquisition
PET/CT
Positron emission tomography
Journal
Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
14
10
2020
accepted:
18
01
2021
pubmed:
8
2
2021
medline:
26
10
2021
entrez:
7
2
2021
Statut:
ppublish
Résumé
To establish the feasibility of shorter acquisition times (and by analogy, applied activity) on tumour detection and lesion contrast in digital PET/CT. Twenty-one randomly selected patients who underwent oncological [ Overall n = 100 lesions were identified in the 2 min and 1 min/bp acquisitions and n = 98 lesions in the 30 s/bp acquisitions. Agreement between the three acquisitions with respect to lesion number and tumour-to-background ratio showed almost perfect agreement (K's α = 0.999). SUVmax, SUVmean and TBR likewise showed > 98% agreement, with longer acquisitions being associated with slightly higher mean TBR (2 min/bp 7.94 ± 4.41 versus 30 s/bp 7.84 ± 4.22, p < 0.05). Shorter acquisition times have traditionally been associated with reduced lesion detectability or the requirement for larger amounts of radiotracer activity. These data confirm that this is not the case for new-generation digital PET scanners, where the known higher sensitivity results in clinically adequate images for shorter acquisitions. Only a small variation in the semi-quantitative parameters SUVmax, SUVmean and TBR was seen, confirming that either reduction of acquisition time or (by analogy) applied activity can be reduced as much as 75% in digital PET/CT without apparent clinical detriment.
Identifiants
pubmed: 33550515
doi: 10.1007/s12149-021-01588-6
pii: 10.1007/s12149-021-01588-6
pmc: PMC7981298
doi:
Substances chimiques
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
485-492Références
J Nucl Med. 2012 Jul;53(7):1041-7
pubmed: 22627001
J Nucl Med. 2015 Sep;56(9):1378-85
pubmed: 26159588
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1745-1750
pubmed: 30617960
J Nucl Med. 2019 Apr;60(4):561-567
pubmed: 30361382
EJNMMI Res. 2019 Dec 10;9(1):106
pubmed: 31823097
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
J Nucl Med. 2020 Nov;61(11):1684-1690
pubmed: 32198313
J Nucl Med. 2020 May;61(5):764-771
pubmed: 31628214
Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1222-1225
pubmed: 30859431
J Nucl Med. 2020 Sep;61(9):1406-1410
pubmed: 32245895
PLoS One. 2020 Mar 16;15(3):e0229560
pubmed: 32176698
J Nucl Med. 2020 Sep;61(9):1376-1380
pubmed: 32005768
J Nucl Med. 2019 Jul;60(7):1031-1036
pubmed: 30630944
J Nucl Med. 2019 Aug;60(8):1059-1065
pubmed: 30683762
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
EJNMMI Phys. 2018 Apr 18;5(1):9
pubmed: 29666972
Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1383-1390
pubmed: 30631910
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):614-623
pubmed: 31792572
J Nucl Med. 2014 Sep;55(9):1411-6
pubmed: 24947059
Nucl Med Commun. 2016 Oct;37(10):1088-94
pubmed: 27281357
J Nucl Med. 2018 Dec;59(12):1817-1822
pubmed: 29880506
J Nucl Med. 2020 Oct;61(10):1448-1454
pubmed: 32060217
Sci Rep. 2020 Jan 15;10(1):368
pubmed: 31942032
J Nucl Med. 2020 Feb;61(2):189-193
pubmed: 31324710
Radiology. 2018 Jan;286(1):249-259
pubmed: 28914600
J Nucl Med. 2011 Feb;52(2):303-10
pubmed: 21233186